Skip to content
INVESTOR | Expres2ion Biotech

INVESTOR | Expres2ion Biotech

Investor Relations

  • News & Events
    • Press Releases
    • Upcoming Events
    • Presentations
    • Financial Calendar
  • Financials
    • Financial reports
  • Governance
    • Articles of Association
    • Management Team
    • Board of Directors
    • General Meetings
    • Company Description
  • Stock Information
    • Stock Quote & Largest Shareholders
    • Analyst Reports
    • IPO and Rights Issues
      • Rights issue 2026
      • Rights Issue 2024
      • Rights Issue 2023
      • Rights Issue 2022
      • Rights Issue 2020
      • Rights Issue 2018
      • Rights Issue 2017
      • Rights Issue 2016 (IPO)
  • Corporate Site

Rights Issue 2023 materials

  • Home
  • Rights Issue 2023 materials

 

Rights Issue 2023

 

TO 8 warrants

  • TO 8 warrant brochure
  • TO 8 warrant application form (Swedish)
  • TO 8 warrant application form (English)

Rights issue press releases

  • Rights Issue Announcement, 3 March 2023 - English
  • Notice to Extraordinary General Meeting, 3 March 2023 - English
  • Bulletin from Extraordinary General Meeting, 23 March 2023 - English
  • Prospectus Publication Announcement, 27 March 2023 - English

Prospectus

  • English
  • Swedish

Rights issue subscription guide

  • English

Rights issue subscription form

  • Digital versions available on Vator Securities' website (Vator Securities acts as Sole Global Coordinator and Sole Bookrunner in the 2023 Rights Issue)
  • Application of interest for subscription with preferential rights - Swedish
  • Application of interest for subscription without preferential rights - Swedish
  • Application of interest for subscription without preferential rights - English

Rights issue registration certificate

  • English
  • Swedish

Articles of association

  • Swedish and English

Financial reports

  • 2022 Year-End Report
    • English
    • Swedish (Summary)
  • 2021 Annual Report, including Auditor's report
    • English
    • Swedish
  • 2020 Annual Report, including Auditor's report
    • English
    • Swedish

Copyright 2010 - All Rights Reserved

EXPRES2ION BIOTECH HOLDING AB
Registration number: 559033-3729
c/o Mindpark
Rönnowsgatan 8C
SE-252 25 Helsingborg, Sweden

R&D
ExpreS2ion Biotechnologies ApS:
CVR/VAT: DK32770487
Agern Allé 1
DK-2970 Hørsholm, Denmark

INVESTOR RELATIONS
investor@expres2ionbio.com

Contact investor relations

MORE INFO
Privacy Policy
Terms & General Conditions
Legal Notice & Disclaimer

Copyright © 2026 INVESTOR | Expres2ion Biotech All rights reserved. Theme: Flash by ThemeGrill. Powered by WordPress